Loading…

Protocol - Program Evaluation: Patient Uptake of Genetic Services

Add to My Toolkit
Description

The reach dimension of Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) includes a four-item checklist used to summarize the characteristics of patients who participate in the uptake of services. Genetic service programs or investigators are expected to report these details when describing patient uptake of genetic services.

Specific Instructions

This protocol is for Implementation Science purposes and should be used when reporting uptake of genetic testing or evaluating an intervention to increase access and uptake of genetic testing that is planned/being conducted. There are various ways to collect this type of information (e.g., medical chart or electronic medical record, other program records, patient self-report), and the method of data collection should be reported. 

Protocol

1. Record the actual number and percent of persons excluded from your study.

_____________________

2. Report the percent of eligible participants who agree to participate in your study.

_____________________

3. Compare differences between those participating and those not participating on illness status, sociodemographics, geography, and other key variables.

_____________________

4. Record reasons that participants refused to participate in the study.

_____________________

Availability

Available

Personnel and Training Required

None

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Program evaluation

Lifestage

Adult

Participants

Patients who participated in genetic testing

Selection Rationale

The checklist was developed and successfully used by the Implementation Science Team at the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences (DCCPS). It is widely used.

Language

English

Standards
StandardNameIDSource
caDSR Common Data Elements (CDE) Genomic Medicine Implementation Patient Genetic Testing Uptake Assessment Text 7408776 CDE Browser
Derived Variables

None

Process and Review

Not applicable

Protocol Name from Source

Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) Checklist for Study or Intervention Planning

Source

National Cancer Institute. (2012). Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) Model Checklist for Study or Intervention Planning Available at http://www.re-aim.org/resources-and-tools/measures-and-checklists/

General References

Glasgow, R. E., & Estabrooks, P. E. (2018). Pragmatic applications of RE-AIM for health care initiatives in community and clinical settings. Preventing Chronic Disease: Public Health Research, Practice, and Policy, 15(E02), 1–7.

Glasgow, R. E., Nelson, C. C., Strycker, L. A., & King, D. K. (2006). Using RE-AIM metrics to evaluate diabetes self-management support interventions. American Journal of Preventative Medicine, 30(1), 67–73.

Wu, R. R., Myers, R. A., McCarty, C. A., Dimmock, D., Farrell, M., Cross, D., Chinevere, T. D., Ginsburg, G. S., & Orlando, L. A. (2015). Protocol for the “Implementation, adoption, and utility of family history in diverse care settings” study. Implementation Science, 10, 163.

Wu, R. R., Myers, R. A., Sperber, N., Voils, C. I., Neuner, J., McCarty, C., Haller, I. V., Harry, M., Fulda, K. G., Cross, D., Dimmock, D., Rakhra-Burris, T., Buchanan, A. H., Ginsburg, G. S., & Orlando, L. A. (2019). Implementation, adoption, and utility of family health history risk assessment in diverse care settings: Evaluating implementation processes and impact with an implementation framework. Genetics in Medicine, 21(2), 331–338.

Protocol ID

311201

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX311201_Patient_Uptake_Genetic_Services_Compare_Participate
PX311201030000 Compare differences between those more
participating and those not participating on illness status, sociodemographics, geography, and other key variables. show less
N/A
PX311201_Patient_Uptake_Genetic_Services_Number_Excluded
PX311201010100 Record the actual number of persons excluded more
from your study. show less
N/A
PX311201_Patient_Uptake_Genetic_Services_Percent_Eligible_Participate
PX311201020000 Report the percent of eligible participants more
who agree to participate in your study. show less
N/A
PX311201_Patient_Uptake_Genetic_Services_Percent_Excluded
PX311201010200 Record the percent of persons excluded from more
your study. show less
N/A
PX311201_Patient_Uptake_Genetic_Services_Reasons_Refused_Participate
PX311201040000 Record reasons that participants refused to more
participate in the study. show less
N/A
Genomic Medicine Implementation
Measure Name

Program Evaluation: Patient Uptake of Genetic Services

Release Date

September 10, 2020

Definition

A checklist used to evaluate uptake of genetic services and testing and the characteristics (e.g., number eligible, and representativeness) of patients willing to participate in genetic testing.

Purpose

The reach dimension of the Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) framework is used to evaluate an intervention. Reach is synonymous with uptake. For genetic services, reach includes the number and characteristics of the individuals who are offered genetic services and elect to proceed with genetic counseling and testing.

Keywords

Reach, genetic counseling, genetic testing, genomic testing, genetic services, Reach Effectiveness Adoption Implementation and Maintenance, RE-AIM, Implementation Science

Measure Protocols
Protocol ID Protocol Name
311201 Program Evaluation: Patient Uptake of Genetic Services
Publications

There are no publications listed for this protocol.